|
NZ201918A
(en)
|
1981-09-18 |
1987-04-30 |
Genentech Inc |
N-terminal methionyl analogues of bovine growth hormone
|
|
US4873192A
(en)
|
1987-02-17 |
1989-10-10 |
The United States Of America As Represented By The Department Of Health And Human Services |
Process for site specific mutagenesis without phenotypic selection
|
|
US5070192A
(en)
|
1988-03-23 |
1991-12-03 |
The Johns Hopkins University |
Cloned human topoisomerase i: cdna expression, and use for autoantibody detection
|
|
EP1690934A3
(en)
|
1990-01-12 |
2008-07-30 |
Abgenix, Inc. |
Generation of xenogeneic antibodies
|
|
US6497872B1
(en)
|
1991-07-08 |
2002-12-24 |
Neurospheres Holdings Ltd. |
Neural transplantation using proliferated multipotent neural stem cells and their progeny
|
|
FR2686087A1
(fr)
|
1992-01-13 |
1993-07-16 |
Inst Nat Sante Rech Med |
Nouvel antigene lymphocytaire, anticorps correspondant et leurs applications.
|
|
US5639856A
(en)
|
1993-09-13 |
1997-06-17 |
The Regents Of The University Of California |
Semaphorin gene family
|
|
US5595756A
(en)
|
1993-12-22 |
1997-01-21 |
Inex Pharmaceuticals Corporation |
Liposomal compositions for enhanced retention of bioactive agents
|
|
US6576754B2
(en)
|
1995-11-09 |
2003-06-10 |
Dana-Farber Cancer Institute |
CD100 antigen and uses therefor
|
|
JP3957765B2
(ja)
|
1997-04-07 |
2007-08-15 |
ジェネンテク・インコーポレイテッド |
抗ｖｅｇｆ抗体
|
|
US6884879B1
(en)
|
1997-04-07 |
2005-04-26 |
Genentech, Inc. |
Anti-VEGF antibodies
|
|
US20020032315A1
(en)
|
1997-08-06 |
2002-03-14 |
Manuel Baca |
Anti-vegf antibodies
|
|
WO1998046769A1
(en)
|
1997-04-11 |
1998-10-22 |
Dendreon Corporation |
Composition and method for inducing an immune response against tumour-related antigens
|
|
EP0892047A3
(de)
*
|
1997-07-09 |
2000-03-08 |
Hoechst Marion Roussel Deutschland GmbH |
Humanes und murines Semaphorin L
|
|
US5968829A
(en)
|
1997-09-05 |
1999-10-19 |
Cytotherapeutics, Inc. |
Human CNS neural stem cells
|
|
US6638501B1
(en)
|
1997-09-29 |
2003-10-28 |
Neurospheres Holdings Ltd. |
Use of multipotent neural stem cell progeny to augment non-neural tissues
|
|
US5958767A
(en)
|
1998-08-14 |
1999-09-28 |
The Children's Medical Center Corp. |
Engraftable human neural stem cells
|
|
AU776865B2
(en)
|
1998-11-10 |
2004-09-23 |
University Of Rochester |
T cells specific for target antigens and methods and vaccines based thereon
|
|
US6737056B1
(en)
|
1999-01-15 |
2004-05-18 |
Genentech, Inc. |
Polypeptide variants with altered effector function
|
|
JP3787473B2
(ja)
|
1999-11-30 |
2006-06-21 |
独立行政法人科学技術振興機構 |
セマフォリン受容体
|
|
US6635742B1
(en)
|
2000-01-25 |
2003-10-21 |
Nuvelo, Inc. |
Antibodies specific for semaphorin-like polypeptides
|
|
AU2913801A
(en)
|
1999-12-23 |
2001-07-03 |
Cornell Research Foundation Inc. |
A method for isolating and purifying multipotential neural progenitor cells and multipotential neural progenitor cells
|
|
CN1329060A
(zh)
|
2000-06-19 |
2002-01-02 |
上海博德基因开发有限公司 |
一种新的多肽——人semaphorin蛋白9和编码这种多肽的多核苷酸
|
|
AU2002329540A1
(en)
|
2001-06-20 |
2003-01-02 |
Morphosys Ag |
Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof
|
|
US20040132101A1
(en)
|
2002-09-27 |
2004-07-08 |
Xencor |
Optimized Fc variants and methods for their generation
|
|
US20080219974A1
(en)
|
2002-03-01 |
2008-09-11 |
Bernett Matthew J |
Optimized antibodies that target hm1.24
|
|
EP1365018A1
(en)
|
2002-05-23 |
2003-11-26 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
CD100 semaphorin in myelination
|
|
DE60334453D1
(de)
|
2002-05-30 |
2010-11-18 |
Macrogenics Inc |
Cd16a bindungsproteine und verwendung zur behandlung von immunkrankheiten
|
|
US9809654B2
(en)
|
2002-09-27 |
2017-11-07 |
Vaccinex, Inc. |
Targeted CD1d molecules
|
|
EP1442749A1
(en)
*
|
2003-01-31 |
2004-08-04 |
Institut National De La Sante Et De La Recherche Medicale (Inserm) |
Use of anti-CD100 antibodies for the treatment and the diagnosis of inflammatory disorder affecting the central nervous system
|
|
CN1788017B
(zh)
*
|
2003-02-10 |
2013-04-24 |
to-BBB控股股份有限公司 |
炎症状态下在血脑屏障中差异表达的核酸
|
|
MXPA05012723A
(es)
|
2003-05-30 |
2006-02-08 |
Genentech Inc |
Tratamiento con anticuerpos anti-vgf.
|
|
CA2882022A1
(en)
|
2003-09-11 |
2005-03-24 |
Walter Newman |
Monoclonal antibodies against hmgb1
|
|
CA2548180C
(en)
|
2003-12-04 |
2014-02-04 |
Vaccinex, Inc. |
Methods of killing tumor cells by targeting internal antigens exposed on apoptotic tumor cells
|
|
US20050233960A1
(en)
|
2003-12-11 |
2005-10-20 |
Genentech, Inc. |
Methods and compositions for inhibiting c-met dimerization and activation
|
|
EP1773885B1
(en)
|
2004-08-05 |
2010-04-21 |
Genentech, Inc. |
Humanized anti-cmet antagonists
|
|
US20060147449A1
(en)
|
2004-11-15 |
2006-07-06 |
Brass Lawrence F |
Method of using CD100 (or Sema4D) to mediate platelet activation and inflammatory responses
|
|
AU2006235271B2
(en)
|
2005-04-07 |
2011-05-19 |
Novartis Vaccines And Diagnostics Inc. |
SEMA4D in cancer diagnosis, detection and treatment
|
|
CA2627966A1
(en)
|
2005-11-16 |
2007-05-24 |
Novartis Ag |
Biomarkers for anti-nogo-a antibody treatment in spinal cord injury
|
|
JP2007308465A
(ja)
|
2006-05-15 |
2007-11-29 |
Boehringer Ingelheim Internatl Gmbh |
炎症性疾患、自己免疫疾患又は骨吸収異常の治療方法
|
|
US8257706B2
(en)
|
2006-08-25 |
2012-09-04 |
Seattle Genetics, Inc. |
CD30 binding agents and uses thereof
|
|
US9382327B2
(en)
|
2006-10-10 |
2016-07-05 |
Vaccinex, Inc. |
Anti-CD20 antibodies and methods of use
|
|
KR20120017469A
(ko)
*
|
2007-01-05 |
2012-02-28 |
유니버시티 오브 취리히 |
질환 특이적 결합 분자 및 표적을 제공하는 방법
|
|
US7919594B2
(en)
|
2007-02-14 |
2011-04-05 |
Vaccinex, Inc. |
Human anti-CD100 antibodies
|
|
JP5357782B2
(ja)
|
2007-02-21 |
2013-12-04 |
バクシネックス インコーポレーティッド |
抗原負荷ＣＤ１ｄ分子によるＮＫＴ細胞活性の調節
|
|
NZ586544A
(en)
|
2007-12-26 |
2012-07-27 |
Vaccinex Inc |
Anti-c35 antibody in combination with an ani-her2 antibody in cancer therapies and methods
|
|
US20090181035A1
(en)
|
2008-01-10 |
2009-07-16 |
Genentech, Inc. |
Plexind1 agonists and their use
|
|
ES2647823T3
(es)
|
2009-05-08 |
2017-12-26 |
Vaccinex, Inc. |
Anticuerpos anti-CD100 y métodos de uso de los mismos
|
|
MX2011012147A
(es)
|
2009-05-15 |
2012-06-19 |
Irx Therapeutics Inc |
Inmunoterapia de vacuna.
|
|
JP5500944B2
(ja)
|
2009-10-29 |
2014-05-21 |
三菱電機株式会社 |
加熱調理器
|
|
NZ604464A
(en)
|
2010-06-14 |
2014-03-28 |
Vaccinex Inc |
Anti-vegf antibodies and uses thereof
|
|
AU2011295902B2
(en)
|
2010-09-02 |
2014-12-04 |
Vaccinex, Inc. |
Anti-CXCL13 antibodies and methods of using the same
|
|
KR102003571B1
(ko)
|
2011-05-13 |
2019-07-24 |
고쿠리츠 다이가쿠호우징 도쿄이카시카다이가쿠 |
골형성 촉진제
|
|
US8790652B2
(en)
|
2011-12-06 |
2014-07-29 |
Vaccinex, Inc. |
Use of the combination of semaphorin-4D inhibitory molecules and VEGF inhibitory molecules to inhibit angiogenesis
|
|
NZ629828A
(en)
|
2012-03-02 |
2017-05-26 |
Vaccinex Inc |
Methods for the treatment of b cell-mediated inflammatory diseases
|
|
US9090709B2
(en)
|
2012-03-28 |
2015-07-28 |
Vaccinex, Inc. |
Anti-SEMA4D antibodies and epitopes
|
|
US9708601B2
(en)
|
2012-04-26 |
2017-07-18 |
Vaccinex, Inc. |
Fusion proteins to facilitate selection of cells infected with specific immunoglobulin gene recombinant vaccinia virus
|
|
US10494440B2
(en)
|
2012-05-11 |
2019-12-03 |
Vaccinex, Inc. |
Use of semaphorin-4D binding molecules to promote neurogenesis following stroke
|
|
EP2951204B1
(en)
|
2013-01-31 |
2019-05-22 |
Vaccinex, Inc. |
Methods for increasing immunoglobulin a levels
|
|
US9371352B2
(en)
|
2013-02-08 |
2016-06-21 |
Vaccinex, Inc. |
Modified glycolipids and methods of making and using the same
|
|
MX377858B
(es)
|
2013-06-25 |
2025-03-11 |
Vaccinex Inc |
Combinación de moleculas inhibidoras de semaforina-4d con agentes inmunomoduladores y usos de los mismos.
|
|
NZ630881A
(en)
|
2013-10-10 |
2016-03-31 |
Vaccinex Inc |
Use of semaphorin-4d binding molecules for treatment of atherosclerosis
|
|
NZ630892A
(en)
|
2013-10-21 |
2016-03-31 |
Vaccinex Inc |
Use of semaphorin-4d binding molecules for treating neurodegenerative disorders
|
|
IL262232B2
(en)
|
2016-04-22 |
2024-06-01 |
Vaccinex Inc |
Integral membrane protein display on poxvirus extracellular enveloped virions
|
|
KR102449406B1
(ko)
|
2016-08-02 |
2022-09-29 |
백시넥스 인코포레이티드 |
백시니아 바이러스/진핵 세포에서 폴리뉴클레오티드 라이브러리를 생산하기 위한 개선된 방법
|
|
CN110325213A
(zh)
|
2017-02-22 |
2019-10-11 |
瓦西尼斯公司 |
神经退行性或神经炎性疾病中胶质细胞活化的早期检测
|